InvestorsHub Logo

The Beef

02/24/17 1:41 PM

#30450 RE: jimbob4stocks #30449

Did you do any research on BMSN or ENTB? You may want to start there. Same guy runs RGBP along with those two. Let me know how those two have fared.

If you think RGBP will be any different, I'd like to know your reasons why. I was once as optimistic as yourself but then I did my research and realized what was really going on.

IMO

The Beef

02/24/17 1:53 PM

#30451 RE: jimbob4stocks #30449

Also let me know if your research was able to dissect this little nugget from an 8-k back in 2015.

Item 8.01 Other Events

On October 30, 2015 Thomas Ichim resigned from his position as Chief Scientific Officer, Director of Research and member of the Board of Directors of Regen Biopharma, Inc. ( “Regen”) due to health reasons.



So the director of this research decided to leave this amazing company that is rolling out some cutting edge scientific technology? Aww poor Ichim. He had to leave due to illness. Understandable.

But wait!..... Thomas Ichim rises from the ashes like a Phoenix and bounces back from his illness to join Batu Biologics as their CSO in December after resigning in October due to an Illness.

Don't believe me, here is the article announcing his presence at Batu.


Hmm makes you wonder what really happened at Regen. Did we not get the full story?

http://www.businesswire.com/news/home/20151221005373/en/Founder-Batu-Biologics-Expands-Involvement-Chief-Scientific

This is just one example with regards to Regen that I feel we are not getting the full story. If you need me to cite others, I'd be more than happy to provide them for you.

IMO